Abstract
Abstract
Background: Kenya has a paediatric HIV burden of nearly 140,000 children, of which only 48% of those on antiretroviral therapy (ART) have achieved the desired viral suppression possibly due to vitamin D deficiency. We explored the influence of vitamin D levels on treatment outcome.
Method: We performed a cross-sectional study of 196 participants aged 3 – 14 years; among them 98 HIV infected who received treatment between 2019 - 2020 in Jaramogi Oginga Odinga Teaching and Referral Hospital, Kenya. The exposure was vitamin D levels, including deficient (<20 ng/ml), insufficient (≥20 - <30 ng/ml), and sufficient (30 – 50ng/ml). The outcome was optimal immune recovery (CD4 ≥ 500 cells/mm3) and optimal viral suppression (viral load ≤ 200 copies/ml). We compared difference in means for each vitamin D category between HIV infected and uninfected using independent t-test, multiple comparisons of vitamin D levels among age categories using ANOVA and post hoc test and Pearson correlation to correlate vitamin D levels, CD4 and viral load of HIV infected children.
Results: Compared with HIV uninfected, HIV infected recorded mean age ± standard deviation of10.65±2.17 years with 39(39.8%) males vs. 6.68±2.81 years with 52(53.1%) males p<0.001; and the difference in vitamin D mean levels was statistically significant [28.21 ± 6.39 infected vs.30.88 ± 6.62 uninfected] t = 2.94, df =194, p = 0.004, 95%CI (0.90 – 4.59). Among age categories, mean vitamin D varied significantly F (2,193) = 10.68, p =0.001; with higher levels observed between 1-4 years category {mean difference 4.64ng/ml, p = 0.02, [95%CI 1.49 – 7.78]} and 5-9 years category {mean difference 4.33ng/ml, p = 0.001, [95%CI 1.89 – 6.38]} as compared to 10 – 14 years respectively.
Additionally, children with optimal immune recovery recorded higher proportion of vitamin D deficiency and insufficiency (12.24% and 42.86%) as compared with sub optimally recovered 1.02% and 4.08%); while children with optimal viral suppression recorded higher proportion of vitamin D deficiency and insufficiency (8.16% and 30.61%) as compared with sub optimally suppressed (5.1% and 16.3%).
Conclusion: Infections with HIV suppresses levels of vitamin D, but this has no influence on CD4 counts and viral load status in children receiving ART.
Publisher
Research Square Platform LLC
Reference30 articles.
1. Patel RC, Oyaro P, Odeny B, Mukui I, Thomas KK. Optimizing viral load suppression in Kenyan children on antiretroviral therapy (Opt4Kids). Contemporary Clinical Trials Communications 20 (2020) 100673; http://www.elsevier.com/locate/conctc, 2020. 20(100673).
2. Increased Risk of Vitamin D Deficiency Among HIV-Infected Individuals: A Systematic Review and Meta-Analysis;Wang Y,2021
3. The Potential Protective Role of Vitamin D Supplementation on HIV-1 Infection;Alvarez N;Front Immunol | www frontiersin org,2019
4. Tindall AM, Schall JI, Seme B, Ratshaa B, Tolle M. Vitamin D status, nutrition and growth in HIVinfected mothers and HIV-exposed infants and children in Botswana. PLOS ONE |; 2020. https://doi.org/10.1371/journal.pone.0236510.
5. Piloya TW, Bakeera–Kitaka S, Kisitu GP, Idro R, Cusick SE. Vitamin D status and associated factors among HIV-infected children and adolescents on antiretroviral therapy in Kampala, Uganda. PLOS ONE |; 2021. https://doi.org/10.1371/journal.pone.0253689.